Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Insulin Glulisine

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sanofi to cut US price of its most-prescribed insulin by 78%
    Sanofi to cut US price of its most-prescribed insulin by 78%

    17 Mar 2023

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-cut-price-its-most-prescribed-insulin-by-78-us-2023-03-16/

    REUTERS
    17 Mar 2023
    Share Share
    Sanofi's Biologic APIDRA (Insulin Glulisine) Receives Approval in the U.S.
    Sanofi's Biologic APIDRA (Insulin Glulisine) Receives Approval in the U.S.

    30 Nov 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021629

    FDA
    30 Nov 2022
    Share Share
    Sanofi talks up personalized diabetes care in patient-centric awareness push
    Sanofi talks up personalized diabetes care in patient-centric awareness push

    10 Jun 2019

    // Beth Snyder Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/sanofi-launches-diabetes-campaign-to-advance-personalized-patient-approach

    Beth Snyder Bulik FIERCE PHARMA
    10 Jun 2019
    Share Share
    FDA Requires New Labeling on Insulin Pens to Ward off Spread of Infections
    FDA Requires New Labeling on Insulin Pens to Ward off Spread of Infections

    03 Mar 2015

    // Varun Saxena FIERCE DRUG DELIVERY

    http://www.fiercedrugdelivery.com/story/fda-requires-new-labeling-insulin-pens-ward-spread-infections/2015-03-03

    Varun Saxena FIERCE DRUG DELIVERY
    03 Mar 2015
    Share Share
    It`s Put Up or Shut Up Time for Sanofi and Mannkind as Afrezza Hits the Market
    It`s Put Up or Shut Up Time for Sanofi and Mannkind as Afrezza Hits the Market

    03 Feb 2015

    // Tracy Staton FIERCE PHARMA

    http://www.fiercepharma.com/story/its-put-or-shut-time-sanofi-and-mannkind-afrezza-hits-market/2015-02-03

    Tracy Staton FIERCE PHARMA
    03 Feb 2015
    Share Share